In recent times, the domestic epidemic has gradually stabilized, but the epidemic in India is still breaking out one after another. At the same time, the multiple mutated strains from India have spread to more than two dozen countries around the world, and many countries are facing severe tests. The New Coronavirus pneumonia epidemic has had a huge negative impact on the global economy and the ensuing huge demand for rapid New Coronavirus nucleic acid testing, but it has also become the first year for China's molecular diagnostics industry to take off.

In the post-epidemic era, the "weathervane" of Nucleic Acid Rapid Test has pointed to overseas. Overseas market has become the future growth pole of Nucleic Acid Rapid Test enterprises. According to statistics, there are more than 1,500 in vitro diagnostic companies, among which there are about 20 manufacturers with the R&D capability of new crown nucleic acid rapid test reagents, and the market competition is getting fierce, and some tracks have entered the red sea. Meanwhile, with the gradual landing of in vitro diagnostic collection, provinces have completed the centralized procurement of new crown nucleic acid rapid test reagents and antigen and antibody detection reagents, and overseas market will definitely become an important source of income for enterprises.

The overseas market has become a secret consensus in the industry. Domestic IVD leader Daan Genetics said it will further strengthen its overseas market capability, speed up overseas certifications such as CE and FDA for its scale up products, and accelerate the pace of global layout and business expansion in overseas markets.

While opening up overseas markets and going overseas, the quality and efficiency of new crown nucleic acid rapid test products have become the core competition point. Compared with traditional nucleic acid tests, which usually take more than 4 hours or even the next day to obtain nucleic acid test results, Daan Gene's nucleic acid rapid test system can produce results within half an hour at the earliest, which is more sensitive, more specific and easier to operate than traditional nucleic acid testing equipment, enabling rapid and immediate nucleic acid rapid tests for high-risk personnel and febrile patients to better meet the epidemic prevention and control It can achieve rapid and instantaneous new crown nucleic acid rapid test for high-risk personnel and fever patients, and better meet the needs of epidemic prevention and control.